SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020041
Filing Date
2021-08-16
Accepted
2021-08-16 14:03:04
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1128170
2 ex31-1.htm EX-31.1 12715
3 ex31-2.htm EX-31.2 12082
4 ex32-1.htm EX-32.1 8945
  Complete submission text file 0001493152-21-020041.txt   5705215

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE eton-20210630.xsd EX-101.SCH 43130
6 XBRL CALCULATION FILE eton-20210630_cal.xml EX-101.CAL 48512
7 XBRL DEFINITION FILE eton-20210630_def.xml EX-101.DEF 226608
8 XBRL LABEL FILE eton-20210630_lab.xml EX-101.LAB 392916
9 XBRL PRESENTATION FILE eton-20210630_pre.xml EX-101.PRE 304082
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 802333
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 211176672
SIC: 2834 Pharmaceutical Preparations